单羧酸转运蛋白1在低糖条件下促进M1型小胶质细胞中诱导型一氧化氮合酶表达

周鹏; 于哲成; 张晓艳; 杨松源; 杜娟娟

doi:10.16098/j.issn.0529-1356.2022.03.003

PDF(4013 KB)

解剖学报 ›› 2022, Vol. 53 ›› Issue (3) : 288-294. DOI: 10.16098/j.issn.0529-1356.2022.03.003

神经生物学

单羧酸转运蛋白1在低糖条件下促进M1型小胶质细胞中诱导型一氧化氮合酶表达

于哲成¹ 张晓艳² 杜娟娟¹ 周鹏^1*

作者信息 +

Monocarboxylate transporter 1 enhancing the expression of inducible nitric oxide synthase within M1 phenotype microglia under low-glucose condition

YU Zhe-cheng¹ ZHANG Xiao-yan² DU Juan-juan¹ ZHOU Peng^1*

Author information +

文章历史 +

摘要

目的探讨在缺血环境下诱导型一氧化氮合酶(iNOS)和单羧酸转运蛋白1(MCT1)与M1型促炎性小胶质细胞的关系。方法小鼠6只，采用光化学栓塞法制作脑缺血模型；BV2细胞使用含5mmol/L低糖培养基刺激2h。使用免疫荧光染色、Western blotting方法检测缺血小鼠大脑中小胶质细胞和低糖刺激的BV2细胞中iNOS、MCT1及精氨酸酶1(ARG1)的表达。用RNA干扰及质粒转染技术分别调控未处理BV2细胞中的MCT1表达，检测iNOS及ARG1的变化。结果激光制作脑缺血模型成功后，缺血侧半球中iNOS和MCT1以及ARG1的表达升高（P<0.01），且MCT1主要表达在离子钙接头蛋白分子1（Iba1）阳性和iNOS阳性的小胶质细胞中。低糖刺激BV2小胶质细胞后，iNOS和MCT1表达升高（P<0.001），而ARG1表达降低（P<0.01），MCT1主要表达在iNOS阳性的BV2细胞中。RNA干扰BV2细胞后，细胞中MCT1表达降低，iNOS表达下降（P<0.01）；质粒转染BV2细胞后，MCT1表达增高，iNOS表达增加（P<0.01）。但在两种情况下，ARG1表达水平均未发生明显变化。结论在低糖环境中小胶质细胞向M1表型极化，MCT1和iNOS表达同时增高，MCT1参与iNOS的表达上调，可能处于iNOS调节通路的上游。

Abstract

Objective To testify the link between the increase of inducible nitric oxide synthase (iNOS) and monocarboxylate transporter 1 (MCT1) expression in the M1 phenotype microglia under ischemic condition. Methods Photothrombosic ischemia stroke model was applied in 6 mice. BV2 cells were treated with low glucose medium contained 5mmol/L glucose for 2 hours. Immunofluorescent staining and Western blotting were used to check the responses from microglia in the mouse brains subjected to ischemia and BV2 cells were treated with low-glucose treatment. Application of RNA interference or plasmid transfection were used to regulate the MCT1 expression in BV2 cells. Results The expression levels of iNOS, MCT1 and arginase-1 (ARG1) increased in the ischemic side compared to the non-ischemic side of mice brain(P<0.01). In the BV2 cells exposed to low-glucose condition, iNOS and MCT1 levels increased(P<0.001), whereas ARG1 level decreased(P<0.01). RNA interference interfered the expression of MCT1 and then decreased the iNOS expression(P<0.01), while overexpression of MCT1 through plasmid transfection increased iNOS expression(P<0.01), while the ARG1 expressions in both conditions were not changed significantly. Conclusion After microglia polarized into inflammatory phenotype during ischemia period, iNOS production is related with MCT1 expression, and MCT1 is in the upstream of iNOS pathway.

导出引用

于哲成张晓艳杜娟娟周鹏. 单羧酸转运蛋白1在低糖条件下促进M1型小胶质细胞中诱导型一氧化氮合酶表达[J]. 解剖学报. 2022, 53(3): 288-294 https://doi.org/10.16098/j.issn.0529-1356.2022.03.003

YU Zhe-cheng ZHANG Xiao-yan DU Juan-juan ZHOU Peng. Monocarboxylate transporter 1 enhancing the expression of inducible nitric oxide synthase within M1 phenotype microglia under low-glucose condition [J]. Acta Anatomica Sinica. 2022, 53(3): 288-294 https://doi.org/10.16098/j.issn.0529-1356.2022.03.003

中图分类号： Q189

参考文献

［1］Wolf SA, Boddeke HW, Kettenmann H. Microglia in Physiology and Disease［J］. Annu Rev Physiol, 2017, 79:619-643.

［2］Collmann FM, Pijnenburg R,Hamzei-Taj S,et al. Individual in vivo profiles of microglia polarization after stroke, represented by the genes iNOS and Ym1［J］. Front Immunol,2019,10:1236.

［3］Liddelow SA,Guttenplan KA,ClarkeK LE,et al. Neurotoxic reactive astrocytes are induced by activated microglia［J］. Nature,2017,541(7638): 481-487.

［4］Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases［J］. Mol Neurobiol,2015, 53(2):1181-1194.

［5］Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases［J］. Trends Mol Med,2017,23(6): 512-533.

［6］Kierdorf K, Prinz M. Microglia: same same, but different［J］. J Exp Med, 2019,2169(10): 2223-2225.

［7］Colonna M,Butovsky O. Microglia function in the central nervous system during health and neurodegeneration［J］. Annu Rev Immunol,2017,35:441-468.

［8］Zhao B, Wang H, Li CX, et al. GPR17 mediates ischemia-like neuronal injury via microglial activation［J］. Int J Mol Med,2018, 42(5): 2750-2762.

［9］Shen Y, Kapfhamer D, Minnella AM, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP［J］. Nat Commun,2017,8(1): 624.

［10］Ghosh S, Castillo E, Frias ES, et al. Bioenergetic regulation of microglia［J］. Glia,2017, 66(6):1200-1212.

［11］Galván-Pe?a S, O’Neill LA. Metabolic reprograming in macrophage polarization［J］. Front Immunol,2014, 5:420.

［12］Salter MW, Stevens B. Microglia emerge as central players in brain disease［J］. Nat Med,2017, 23(9): 1018-1027.

［13］Hashimoto T, Hussien R,Cho HS, et al. Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles［J］. PLoS One, 2008,3(8): e2915.

［14］Moreira TJ, Maekawa F, Repond C,et al. Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells［J］, J Cereb Blood Flow Metab,2009, 29(7): 1273-1283.

［15］Kong L, Wang Z, Liang X, et al. Monocarboxylate transporter 1 promotes classical microglial activation and proinflammatory effect via 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase3［J］. J Neuroinflammation, 2019,16(1):240.

［16］Zhao Z,Wu MS, Zou C,et al. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway［J］.Cancer Letters,2014,342(1)150-158.

［17］Huang C,Lu X, Wang JL, et al. Compound C induces the ramification of murine microglia in an AMPK-independent and small rhogtpase-dependent manner［J］. Neuroscience,2016, 331:24-39.

［18］Subedi L, Lee JH, Yumnam S, et al. Anti-inflammatory effect of sulforaphane on LPS-activated microglia potentially through JNK/AP-1/NF-kB inhibition and Nrf2/HO-1 activation［J］. Cells,2019,8(2):194.

［19］Yang L, Renyuan Zhoua, Yu Tong,et al. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation［J］. Neurobiol Dis，2020，140：104814.

［20］Du JJ，Ye Zh，Zhou T，et al. Small ubiquitin-like modifier proteins specific protease 3 in microgliaparticipating in the early progression of photothrombosic ischemic stroke mice model［J］. Acta Anatomica Sinica,2021,52(4):548-553.(in Chinese)

杜娟娟，叶蓁，周涛，等.小胶质细胞中小泛素样修饰蛋白特异性蛋白酶3参与小鼠光化学栓塞法缺血性脑卒中早期的疾病进展［J］.解剖学报,2021，52(4)：548-553.

［21］Sickmann HM, Walla AB, Schousboe A, et al. Functional significance of brain glycogen in sustaining glutamatergic neurotransmission［J］. J Neurochem,2009, 109（Suppl 1）: 80-86.

［22］Zhou P,Guan T, Jiang Z,et al. Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses［J］. CNS Neurosci Ther,2018, 24(2):126-134.

［23］Pereira-Vieira J, Preto A, Casal M, et al. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions［J］. Biol Chem,2019,400(6):787-799.

［24］Yue Y,Stone S,Lin W. Role of nuclear factor kappaB in multiple sclerosis and experimental autoimmune encephalomyelitis［J］. Neural Regen Res,2018,13(9):1507-1515.